Showing results (111-120 of 566) with videos related to

Sort By:
Pageof 57
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximabJ Boye, T Elter, A Engert
Leukemia Research|January 1, 1991
Resistance of myeloid leukaemia cell lines to ricin A-chain immunotoxinsA Engert, A Brown, P Thorpe
Der Internist|May 29, 2020
[Checkpoint inhibitors in Hodgkin lymphoma]S Sasse, J Momotow, A Engert
International Journal of Molecular Medicine|October 13, 2000
Recombinant immunotoxins for the treatment of Hodgkin's disease (Review)B Matthey, A Engert, S Barth
European Journal of Haematology. Supplementum|July 13, 2005
Immunotherapy of Hodgkin's lymphomaP Borchmann, R Schnell, A Engert
Medizinische Klinik (Munich, Germany : 1983)|August 16, 2000
[Long-term toxic sequelae of the treatment of Hodgkin's disease]K Breuer, V Diehl, U Rüffer
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Report on the workshop biology of the Third International Symposium on Hodgkin's Lymphoma in Cologne 1995J Wolf, H Bohlen, V Diehl
Strahlentherapie|August 1, 1985
[Bone scintigraphy for the staging of lymphogranulomatosis?]H Hundeshagen, V Diehl, H Creutzig
Versicherungsmedizin|October 1, 1995
[Prognostic relevance of oncologic after-care]T Schumacher, S Schmitz, V Diehl
Praxis|March 19, 1996
[Clinical aspects and primary therapy of Hodgkin's lymphomas]M Sieber, H Tesch, V Diehl
Pageof 57